Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
Titel:
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
Auteur:
Pfister, Christian Gravis, Gwenaelle Flechon, Aude Chevreau, Christine Mahammedi, Hakim Laguerre, Brigitte Guillot, Aline Joly, Florence Soulie, Michel Allory, Yves Harter, Valentin Culine, Stéphane